PL2207567T3 - Preparat immunogenny - Google Patents

Preparat immunogenny

Info

Publication number
PL2207567T3
PL2207567T3 PL08832386T PL08832386T PL2207567T3 PL 2207567 T3 PL2207567 T3 PL 2207567T3 PL 08832386 T PL08832386 T PL 08832386T PL 08832386 T PL08832386 T PL 08832386T PL 2207567 T3 PL2207567 T3 PL 2207567T3
Authority
PL
Poland
Prior art keywords
immunogenic formulation
immunogenic
formulation
Prior art date
Application number
PL08832386T
Other languages
English (en)
Inventor
Parra Alexis Mikes Kalergis
Munoz Pablo Alberto Gonzalez
Ramirez Susan Marcela Bueno
Original Assignee
Univ Pontificia Catolica Chile
Bestpharma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pontificia Catolica Chile, Bestpharma S A filed Critical Univ Pontificia Catolica Chile
Publication of PL2207567T3 publication Critical patent/PL2207567T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08832386T 2007-09-20 2008-09-17 Preparat immunogenny PL2207567T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CL2007002710A CL2007002710A1 (es) 2007-09-20 2007-09-20 Formulacion inmunogenica que confiere proteccion contra la infeccion o patologia causada por el virus respiratorio sincicial (vrs) que comprende una cepa recombinante atenuada de mycobacterium; y uso de la formulacion inmunogenica para preparar una vacuna para prevenir, tratar o atenuar infecciones del vrs.
EP08832386.0A EP2207567B1 (en) 2007-09-20 2008-09-17 Immunogenic formulation
PCT/US2008/076682 WO2009039178A1 (en) 2007-09-20 2008-09-17 Immunogenic formulation

Publications (1)

Publication Number Publication Date
PL2207567T3 true PL2207567T3 (pl) 2015-06-30

Family

ID=51399051

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08832386T PL2207567T3 (pl) 2007-09-20 2008-09-17 Preparat immunogenny

Country Status (10)

Country Link
US (1) US8398993B2 (pl)
EP (1) EP2207567B1 (pl)
CN (1) CN101918029B (pl)
AR (2) AR067425A1 (pl)
CL (1) CL2007002710A1 (pl)
DK (1) DK2207567T3 (pl)
ES (1) ES2528197T3 (pl)
PE (1) PE20090653A1 (pl)
PL (1) PL2207567T3 (pl)
WO (1) WO2009039178A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102021149B (zh) * 2010-07-27 2013-04-24 张卫东 基因ns1缺陷型呼吸道合胞病毒及其治疗肺癌的应用
WO2013155205A1 (en) 2012-04-10 2013-10-17 The Trustees Of The University Of Pennsylvania Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
WO2014005643A1 (en) * 2012-07-05 2014-01-09 Okairos Ag Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides
CL2013002829A1 (es) * 2013-10-01 2014-04-04 Univ Pontificia Catolica Chile Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv.
CA2951430A1 (en) 2014-06-13 2015-12-17 Glaxosmithkline Biologicals Sa Immunogenic combinations
CN104593389A (zh) * 2015-01-27 2015-05-06 吉林大学 一种重组合胞病毒蛋白及其应用
CL2019003847A1 (es) * 2019-12-26 2021-08-06 Univ Pontificia Catolica Chile Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv
CL2020000857A1 (es) 2020-03-31 2021-11-05 Univ Pontificia Catolica Chile Nuevo uso de formulación inmunogénica bcg que expresa una proteína del virus respiratorio sincicial humano contra bvrs en bovinos
CN114748615A (zh) * 2022-04-29 2022-07-15 成都安永鼎业生物技术有限公司 一种治疗用重组卡介苗的冻干制剂及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566121B1 (en) * 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
FI935566A0 (fi) * 1991-06-13 1993-12-10 Einstein Coll Med Insertionsmutationer i mycobakterier
US20020081317A1 (en) * 1999-02-02 2002-06-27 Mahan Michael J. Bacteria with altered DNA adenine methylase (DAM) activity and heterologous epitope
WO2002009749A2 (en) * 2000-07-31 2002-02-07 Aventis Pasteur Limited Respiratory syncytial virus vaccine
EP1404368B1 (en) * 2001-06-07 2009-12-09 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
US7070786B2 (en) * 2003-06-06 2006-07-04 Centocor, Inc. RSV proteins, antibodies, compositions, methods and uses
WO2007050099A2 (en) * 2004-12-01 2007-05-03 Aeras Global Tb Vaccine Foundation Recombinant bcg strains with attenuated immunosuppresive properties

Also Published As

Publication number Publication date
PE20090653A1 (es) 2009-06-20
US20110200634A1 (en) 2011-08-18
US8398993B2 (en) 2013-03-19
DK2207567T3 (en) 2015-01-26
EP2207567A1 (en) 2010-07-21
CN101918029A (zh) 2010-12-15
EP2207567A4 (en) 2013-05-01
CN101918029B (zh) 2015-05-20
CL2007002710A1 (es) 2008-01-04
EP2207567B1 (en) 2014-11-05
AR067425A1 (es) 2009-10-14
ES2528197T3 (es) 2015-02-05
AR116662A2 (es) 2021-06-02
WO2009039178A1 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
ZA200808489B (en) Nicotine-carrier vaccine formulation
GB0711656D0 (en) Formulations
ZA201004439B (en) Formulation
GB0716385D0 (en) Formulations
GB0815435D0 (en) Formulations
GB0712884D0 (en) Formulations
GB0720716D0 (en) Novel formulation
GB0823269D0 (en) Formulations
GB0807905D0 (en) Formulations
GB0809979D0 (en) Formulations
ZA201102446B (en) Oral formulation
GB0821789D0 (en) Formulations
GB0711957D0 (en) Formulations
PL2207567T3 (pl) Preparat immunogenny
GB0707463D0 (en) Formulation
EP2307021A4 (en) FORMULATIONS
GB0822633D0 (en) Formulation
GB0810232D0 (en) Formulations
GB0800788D0 (en) Niovel formulation
GB0715723D0 (en) Formulation
GB0814376D0 (en) Formulation
GB0712972D0 (en) Formulation
GB0705179D0 (en) Formulations
ZA200806951B (en) Homeopathy-based formulation
GB0916030D0 (en) Formulations